BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/28/2020 8:47:57 AM | Browse: 1311 | Download: 2288
Publication Name World Journal of Rheumatology
Manuscript ID 57514
Country United States
Received
2020-06-12 02:29
Peer-Review Started
2020-06-12 02:30
First Decision by Editorial Office Director
2020-10-21 21:06
Return for Revision
2020-10-21 21:06
Revised
2020-10-26 23:20
Publication Fee Transferred
Editorial Processing by Scientific Editor
2020-11-04 09:54
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2020-11-05 19:27
Articles in Press
2020-11-05 19:27
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-12-10 02:41
Publish the Manuscript Online
2020-12-28 08:47
ISSN 2220-3214 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Health Care Sciences & Services
Manuscript Type Retrospective Study
Article Title Greater awareness of biosimilars and shared decision-making among patients attending rheumatology practices in Colorado, United States: Real-world data
Manuscript Source Unsolicited Manuscript
All Author List Rovshan Ismailov, Steven Simoens and Zaytuna Khasanova
ORCID
Author(s) ORCID Number
Rovshan Ismailov http://orcid.org/0000-0002-1394-3599
Steven Simoens http://orcid.org/0000-0002-9512-2005
Zaytuna Khasanova http://orcid.org/0000-0002-1294-3992
Funding Agency and Grant Number
Corresponding Author Rovshan Ismailov, MD, N/A, PhD, Research Scientist, Complex Mechanisms of Disease, Aging and Trauma Research Foundation, PO Box 460722, Denver, CO 80246, United States. dr.ismailov@cmdat.org
Key Words Patients; Biosimilars; Shared decision-making; Education; Survey; Awareness
Core Tip What is already known about this subject? Clinical research indicates that the introduction of biosimilars will not compromise either efficacy or safety for patients with rheumatic diseases such as rheumatoid arthritis. Unfortunately, there is a lack of knowledge and awareness regarding biosimilars among these patients. Very limited research of rheumatology patients’ knowledge, and awareness of biosimilars and shared decision-making, as well as motivation to learn more about these subjects exists. What does this study add? Consistently with several other studies, many patients attending rheumatology practices in Colorado have a low level of knowledge and awareness of shared decision-making and, especially, biosimilars. Moreover, most of these patients do not engage in important discussions regarding treatment plans or options with their doctors. As our survey respondents gained knowledge about biosimilars and shared decision-making from our printing materials it seems that educational programs enriched with printed materials may impact patients’ knowledge and awareness of biosimilars as well as shared decision-making. How might this impact on clinical practice or future developments? As we have become aware of which style of learning our survey respondents prefer regarding biosimilars and shared decision-making, we believe that prospective projects will benefit not only from booklets, but also from online presentations and webinars. Based on our current study results, we recommend adding more survey questions focused on shared decision-making such as discussing treatment plans and options with doctors.
Publish Date 2020-12-28 08:47
Citation Ismailov R, Simoens S, Khasanova Z. Greater awareness of biosimilars and shared decision-making among patients attending rheumatology practices in Colorado, United States: Real-world data. World J Rheumatol 2020; 10(1): 1-10
URL https://www.wjgnet.com/2220-3214/full/v10/i1/1.htm
DOI https://dx.doi.org/10.5499/wjr.v10.i1.1
Full Article (PDF) WJR-10-1.pdf
Full Article (Word) WJR-10-1.docx